Company: ACHV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-268074
Chunk: 7

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
Achieve Life Sciences, Inc.

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share and share amounts)  

     September 30,

     December 31,

     2025

     2024

     ASSETS

     Current assets:

     Cash and cash equivalents [note 5]
      
     $
     31,930

     $
     12,753

     Marketable securities [note 5]

     16,184

     21,607

     Prepaid expenses and other assets

     1,941

     2,107

     Total current assets

     50,055

     36,467

     Other assets and restricted cash [note 5]

     65

     39

     Right-of-use assets [note 9]

     79

     119

     License agreement [note 3 and note 4]

     807

     974

     Goodwill

     1,034

     1,034

     Total assets
      
     $
     52,040

     $
     38,633

     LIABILITIES AND STOCKHOLDERS’ EQUITY

     Current liabilities:

     Accounts payable
      
     $
     1,943

     $
     1,950

     Accrued liabilities other

     1,802

     573

     Accrued clinical liabilities

     850

     1,077

     Accrued compensation

     2,429

     3,027

     Current contingent consideration [note 4 and note 5]

     1,443

     —

     Current portion of long-term obligations [note 9]

     59

     55

     Current portion of convertible debt [note 5 and note 6]

     1,204

     —

     Total current liabilities

     9,730

     6,682

     Non-current liabilities

     Non-current portion of convertible debt [note 5 and note 6]

     8,674

     9,837

     Non-current contingent consideration [note 4 and note 5]

     —

     1,149

     Long-term obligations [note 9]

     21

     66

     Total liabilities

     18,425

     17,734

     Commitments and contingencies [note 9]